Synergistic application of Positron Emission Tomography (PET) and high-resolution Magnetic Resonance Spectroscopic Imaging (MRSI) for accurate tumor delineation in radiation therapy treatment planning of glioblastomas

正电子发射断层扫描 (PET) 和高分辨率磁共振波谱成像 (MRSI) 的协同应用在胶质母细胞瘤放射治疗计划中准确描绘肿瘤

• 批准号: 436180
• 负责人: Nosrati Reyhaneh
• 金额: $ 10.2万
• 依托单位: Massachusetts General Hospital (Boston)
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-10-01 至 2022-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=436180&lang=en
• 关键词: Glioblastoma (Gbm); Gross Tumor Volume (Gtv); High Resolution; Magnetic Resonance Spectroscopic Imaging (Mrsi); Metabolic Imaging; Positron Emission Tomography (Pet); Quantitative Mri; Radiation Therapy; Radiation Therapy Treatment Planning; Tumor Delinea

Glioblastoma is the most aggressive and lethal type of brain cancer accounting for 50% of all brain tumors. Despite extensive research aiming to improve GBM treatment, treatment efficacy is still extremely poor and the current 5-year survival rate is only

胶质母细胞瘤是最具侵袭性和致命性的脑癌类型，占所有脑肿瘤的50%。尽管广泛的研究旨在改善GBM治疗，但治疗效果仍然极差，目前的5年生存率仅为10%。